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tuberculosis remains the world’s leading cause of death from an infectious agent, and is a serious 
health problem in Papua New Guinea (PNG) with an estimated 36,000 new cases each year. This study 
describes the genetic diversity of Mycobacterium tuberculosis among tuberculosis patients in the 
Balimo/Bamu region in the Middle fly District of Western province in pnG, and investigates rifampicin 
resistance-associated mutations. Archived Ziehl-neelsen-stained sputum smears were used to conduct 
microbead-based spoligotyping and assess genotypic resistance. Among the 162 samples included, 
80 (49.4%) generated spoligotyping patterns (n = 23), belonging predominantly to the L2 Lineage 
(44%) and the L4 Lineage (30%). This is consistent with what has been found in other PNG regions 
geographically distant from Middle Fly District of Western Province, but is different from neighbouring 
South-East Asian countries. Rifampicin resistance was identified in 7.8% of the successfully sequenced 
samples, with all resistant samples belonging to the L2/Beijing Lineage. A high prevalence of mixed 
L2/L4 profiles was suggestive of polyclonal infection in the region, although this would need to be 
confirmed. The method described here could be a game-changer in resource-limited countries where 
large numbers of archived smear slides could be used for retrospective (and prospective) studies of M. 
tuberculosis genetic epidemiology.
Papua New Guinea (PNG) is one of the ten high tuberculosis (TB) burden countries worldwide with a TB noti-
fication rate of 333 per 100,000 people (n = 28,244) in 20161. The World Health Organization (WHO)-estimated 
incidence rate was 432 cases per 100,000 population (95% CI 352 to 521) in 2017, accounting for 36,000 new 
cases and 4,300 deaths2. The TB burden can be even higher in rural areas of PNG, with estimated incidence 
rates of 1,290 cases per 100,000 population in Gulf Province and 550 cases per 100,000 in Western Province 
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(WP)3,4. Considering that HIV (a major driver of TB in sub-Saharan Africa) accounts for only about 5–10% of 
TB cases in PNG, these estimated incidence rates are remarkably high4. PNG is also considered to have a high 
burden of rifampicin-resistant TB (RR-TB) and multidrug-resistant TB (MDR-TB), defined as resistance to at 
least rifampicin (RIF) and isoniazid (INH)2. In 2017, the proportion of RR-TB and MDR-TB (referred to as MDR/
RR-TB) was estimated to be 3.4% of new TB cases and 26% of retreatment cases2.
Comparing the genetic diversity of Mycobacterium tuberculosis (Mtb) within and between different popula-
tions provides insights into TB dynamics at different levels, and may help improve control strategies developed by 
national TB control programs. Seven lineages of human adapted M. tuberculosis complex (MTBC) have been iden-
tified5. The so-called “modern lineages” (Lineages 2, 3 and 4) are widespread, while the “ancient” (Lineages 1, 5 and 
6) show spatial heterogeneity6. Modern lineages have been suggested to have increased virulence or transmissibility, 
which may have evolved as a response to co-evolutionary interactions with particular human populations, or to 
mass BCG vaccination and use of antituberculosis drugs7. In PNG, molecular epidemiology studies based on MTBC 
clinical isolates are scarce. Two studies, published in 20128 and in 20149 investigated the diversity of Mtb in differ-
ent PNG provinces with cultured samples using spoligotyping, a method using the CRISPR locus (clustered regu-
larly interspaced short palindromic repeats) as a target for Mtb subtyping10. Mtb isolates originating from adult TB 
patients from Madang and surrounds belonged predominantly to Lineage 4 and Lineage 2, and 44% of isolates were 
molecularly clustered, suggesting active Mtb transmission in the community8. Spoligotyping of Mtb isolates from 
Goroka (Eastern Highlands), Madang (Madang Province) and Alotau (Milne Bay) revealed L4, L2, and L1 Lineages 
as the main Mtb lineages at all three sites9. More recent studies also used variable number of tandem repeats (VNTR) 
and whole genome sequencing (WGS) to understand the genetic diversity of circulating strains, and revealed drug 
resistance-associated mutations on Daru Island, in the South Fly District WP, PNG11,12. In Daru, a cluster of MDR/
RR-TB (n = 95) was identified as belonging to a single L2/Beijing sub-lineage 2.2.1.112. Nevertheless, the diversity of 
Mtb in PNG remains largely unexplored, and no information is available from the Middle Fly District WP.
Overall, facilities for culturing clinical isolates and testing them for drug susceptibility are lacking in PNG. 
In the Middle Fly District WP, the catchment area for Balimo District Hospital (BDH) primarily includes the 
population of the ‘Balimo Urban’ and ‘Gogodala Rural’ local level government (LLG) areas, and to a lesser degree 
the ‘Bamu Rural’ LLG. This area is hereafter referred to as the “Balimo/Bamu region”. BDH does not have facilities 
for performing Mtb culture and is not equipped with a GeneXpert (Cepheid) instrument, so TB diagnosis relies 
primarily on clinical presentation and direct sputum smear microscopy, based on the PNG National Tuberculosis 
Management Protocol13–15. DNA extracted from Ziehl-Neelsen (ZN) stained sputum smears has already proven 
useful in molecularly confirming the microscopy diagnosis of TB in this region of PNG14, and spoligotyping 
has been undertaken successfully on DNA extracted from cultures10,16, from decontaminated sputa17, as well 
as from ZN-stained sputum smears18–21. Direct sputum smear microscopy is routinely performed in diagnos-
tic laboratories worldwide, including in developing countries, and stained slides can be stored and transported 
at room temperature, which makes them a prime target for spoligotyping of Mtb samples collected in remote 
settings21. Spoligotyping has been historically performed by reverse hybridization on a nylon membrane22 but 
microbead-based systems improve throughput and sensitivity10,23. We performed microbead-based spoligotyp-
ing and molecular analysis of ZN-stained sputum smears collected in the Balimo/Bamu region in the Middle Fly 
District WP, PNG, in order to (i) assess the efficacy of the spoligotyping method when using archived samples 
collected under routine programmatic conditions in a remote location, (ii) analyse the genetic diversity and dis-
tribution of Mtb, and (iii) identify RIF-resistant TB among newly diagnosed TB patients.
Results
clinical sample set. A total of 345 smeared sputa were collected from June 2012 to March 2014, of which 
206 showed evidence of mycobacterial DNA based on combined TaqMan qPCR assays (see14 for details). Out of 
those 206 qPCR-positive samples, the spoligotyping and resistance analyses focused on the ones with the lowest 
Cq values after qPCR, with a cutoff of 36 chosen from preliminary spoligotyping results. Samples included in 
the analyses (n = 162) are summarised in Table 1, with their detailed microscopy results. The excluded samples 
(n = 44; Cq > 36) were mostly negative in microscopy (36 negative, 3 scanty, 5 unknown).
Genotypic diversity of the clinical isolates. Spoligotyping of Mtb was successfully conducted in 49.4% 
(80/162) samples (Table 1). Interpretable spoligotyping results were obtained for 92% (57/62) of the sputum 
smears showing ‘3+’ and ‘2+’ microscopy results; the spoligotyping success dropped to 41% (12/29) for the 
Microscopy 
results
qPCR-
positive Spoligotyping
Spoligotyping-based 
lineage assignations
3+ 47 42 16 L4; 23 L2; 3 mixed
2+ 15 15 2 L4; 6 L2; 6 mixed; 1 L1
1+ 22 9 3 L4; 1 L2; 5 mixed
scanty 7 3 1 L4; 2 mixed
negative 54 6 1 L4; 1 L2; 4 mixed
unkown 17 5 1 L4; 4 L2
Total 162 80 24 L4; 35 L2; 20 mixed; 1 L1
Table 1. Detailed microscopy results of the included qPCR-positive sputum smears (n = 162), and of the 
successfully spoligotyped samples. ‘Mixed’: spoligotype pattern interpreted as an intermediate L2/L4 lineage.
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sputum smears with ‘1+’ and ‘scanty’ microscopy results. Three of seven worldwide reported Mtb lineages were 
detected in the Balimo/Bamu region (Table 1). Among the 80 independent samples with successful genotyping, 
modern Lineages L2 and L4 were most prevalent, representing 44% (35/80) and 30% (24/80) of the samples 
respectively. In contrast, ancient L1 Lineage was very rare (1%; 1/80). Nine spoligotype profiles were atypical 
(only one reported in SITVIT2, one reported in Madang, PNG, and all giving contradictory labellings with 
TBminer), and careful exploration of raw signals showed intermediate values for several spacers, especially sp35 
and sp36 that are absent in L4 Lineage and present in L2 Lineage. These mixed patterns likely corresponded to 
mixed infections of L2 and L4 strains as reported in other studies (see Discussion) and represented 25% (20/80) 
of the samples (Table 1). When excluding ‘mixed’ samples, the prevalences per lineage were 2% (1/60) for L1, 58% 
(35/60) for L2, and 40% (24/60) for L4.
Twenty-three different spoligotyping patterns belonged to 13 different families and five clusters with two or 
more samples (Fig. 1). The largest clusters were L2/Beijing SIT1 (n = 34), one new L4 pattern (likely L4.2/Ural1 
according to TBminer) (n = 9), and one pattern labelled as ‘mixed’ (n = 11). Of the 23 patterns identified, eight 
patterns (n = 44 samples) have already been described in PNG, including four patterns described in the two pre-
vious PNG studies8,9 as well as ours: L2/Beijing SIT1, L4/H3 SIT50, L4/T1 SIT53 and L4/T1 SIT393 (Fig. 1). The 
other 15 patterns (n = 36 samples) were “new” in PNG. Of note, eight patterns were detected in the two previous 
PNG studies8,9 but were not identified in the Balimo/Bamu region, including L4/X1 SIT119 and L4/LAM9 SIT42 
that each accounted for 6% of spoligotypes in Madang8.
Spatial analysis of Mtb lineages in pnG. Figure 2 shows the distribution of Mtb diversity according to 
previous investigations in PNG (Fig. 2B) and the present study (Fig. 2B,C). L2 and L4 Lineages were present in all 
PNG settings, while L1 Lineage was detected in samples from three locations out of the five regions investigated, 
including the Balimo/Bamu region where it was detected in one sample (Fig. 2C). However, the relative percent-
age of each lineage varied between locations at the national level (Fig. 2B) as well as at the regional level (Fig. 2C). 
In the present study, the biggest spatial cluster (n = 8) corresponds to the town of Balimo (Fig. 2C).
Rif-resistance associated mutations. RIF-resistance was assessed by sequencing a 147-bp region of the 
rpoB gene (including RRDR). Out of the 162 qPCR-positive sputum smears included in the analyses, 116 (71.6%) 
were successfully sequenced (Table 2). Mutations were identified in 7.8% (95% CI 2.9–12.6%) of the successfully 
sequenced samples, and all corresponded to the rpoB S450L codon mutation (Table 2). Of note, one sample that 
tested positive for mycobacterial DNA based on qPCR resulted in a rpoB sequence originating from Pseudomonas 
aeruginosa. Considering that this sample showed a late positive qPCR (Cq 33.3 and 35.5), a negative microscopy 
result, but a ‘1 +’ microscopy result on another slide from the same patient sampled the previous month, we 
believe this patient to be a true but low MTBC positive and a mixed sample containing MTBC and Pseudomonas.
Among the 79 sputum smears with both rpoB and spoligotyping results, 72 were rpoB wild type and seven 
were S450L mutants, with all the RIF-resistant samples belonging to the L2/Beijing Lineage (Fig. S1). Drug resist-
ance was thus linked with Lineage 2 (Fisher exact test p = 0.003), as already observed in a study conducted at 
Modilon General Hospital, Madang Province8.
Discussion
The spoligotyping method is known to have limited discriminatory capacity due to the fact that it targets only a 
single genetic locus, covering less than 0.1% of the Mtb genome, and when used alone, is not sufficient for epi-
demiological linking studies24. Nevertheless, spoligotyping allows identification of most if not all genotypes of 
significant, clinical, and epidemiological relevance, such as the “Beijing” genotype24. In this study, we used spol-
igotyping to describe the genetic diversity of Mtb from patients presenting at BDH, originating from the Middle 
Fly District WP, PNG. We show a wide diversity of spoligotype patterns in the Balimo/Bamu region, and confirm 
the presence of the modern L2 and L4 Lineages, with a single ancient L1 Lineage case, originating from the Bamu 
LLG. We also analysed drug-resistance associated mutations in the rpoB gene, and identified 7.8% of the success-
fully sequenced samples showing RIF resistance, all being L2/Beijing Lineage isolates.
Populations in the Highlands are the oldest settlers of PNG, as shown by human genetic studies25, and have 
been isolated from the outside world for much longer than the populations in coastal sites. For this reason it was 
expected that evolutionary ancient lineages of Mtb (e.g. L1 Lineage) would be found in the low density popula-
tions of the Highlands, as opposed to modern lineages of Mtb (L2 and L4 Lineages) that would be found in the 
high density populations of the coastal regions9. However, a recent human genetic study determined that the 
genetic differentiation between populations from highland and lowland PNG does not seem to be as significant 
as previously thought26, and no statistically significant difference in the prevalence of L1 Lineage could be found 
in Goroka, Eastern Highlands, compared to coastal regions9. In the end, the pattern of dominance of modern lin-
eages over ancient L1 Lineage seems consistent across PNG, with the 2% of L1 Lineage found in the Balimo/Bamu 
region not dissimilar to the 0.6% (1/173) to 8% (3/38) observed in the North Coast (East Sepik, Madang), Goroka 
or Alotau8,9. This pattern is strikingly different from what has been described in neighbouring South-East Asian 
countries. In Western New Guinea (WNG), i.e. the Indonesian part of the island, the same three lineages have 
been reported, but with a higher proportion of L1 Lineage (33.7%)27. This is also true in other countries of the 
region, with L1 Lineage representing 30.2% of samples in Makassar, Indonesia28, 56.4% in Malaysia29, and 36.3% 
in southern Vietnam30. This might be due to different importation histories of TB strains in PNG compared to 
the rest of South-East Asia. For example, it has been suggested that ancient TB lineages might have been replaced 
early on by modern and more successful lineages with the arrival of Europeans in PNG in the late 19th century31.
In L4 Lineage, Latin-American and Mediterreanean (LAM) families (Lineage 4.3) were the most prevalent 
in WNG, as compared to PNG where other L4 families were found in high proportion in most of the locations. 
Interestingly, L4/SIT393 is reported in the three independent studies performed so far in PNG. L4/SIT393 is 
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characterized by the absence of spacer sp14, a character that has not yet been shown to be monophyletic. A total 
of 60 cases have now been reported in PNG (Fig. 1), whereas until now, only 36 cases were described worldwide 
in SITVIT232. The largest and best collection of L4 Lineage characterized so far in PNG has been described by 
Stucki and colleagues33 that report, within the L4 Lineage, up to 40% of L4.10/PGG3 (Principal Genetic Group 3) 
strains, characterized by the katG463-CGG (Arg) plus gyrA95-AGC (Ser) combination and the Rv1501 C- > A 
Figure 1. Spoligotype patterns and lineages detected in our study and in previous studies from different 
provinces in PNG. The present study focuses on patients from the Balimo/Bamu region (Middle Fly District of 
Western Province), all diagnosed at the Balimo District hospital. The Baillif et al. 2012 study8 focuses on patients 
from Madang Province, East Sepik Province and “other”, all diagnosed at the main hospital of Madang Province 
(Modilon General Hospital). The Ley et al. 2014 study9 focuses on patients from Madang (Madang Province), 
Goroka (Eastern Highlands Province) and Alotau (Milne Bay Province).
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allelic change34,35. We suggest that L4/SIT393 isolated in PNG could belong to the L4.10/PGG3 lineage. Future 
work should focus on SNP characterization of these isolates in PNG, and related analyses should shed interesting 
light into diversity at the sublineage level.
Figure 2. Spatial distribution of Mtb spoligotyping-defined lineages in Papua New Guinea. (A) Localization of 
previous study settings, as well as the present study in the Balimo/Bamu region, Middle Fly District of Western 
Province (red square). (B) Distribution of Mtb lineages at the regional level in Goroka, Alotau, Madang9, 
Madang Province and East Sepik Province8 and the Balimo/Bamu region (this study). (C) Distribution of Mtb 
lineages at the subregional level in the Balimo/Bamu region. Size of circle is proportional to the number of 
TB cases (n). Local level government (LLG) areas are delimited in grey lines, with TB cases in (C) located in 
the Gogodala Rural (southwest, including the Balimo Urban LLG) and Bamu Rural (northeast) LLGs. Undet: 
undetermined (including intermediate L2/L4 patterns; see main text for further explanation).
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An interesting result from our analysis was the likely identification of many mixed (or polyclonal) infections, 
which are infections with several different genotypes/strains of Mtb in a single patient36. In our study, many spol-
igotype patterns could be assigned as MANU2 in SITVIT2, but have been assigned as “mixed” patterns in our 
analysis, with strains harboring superimpositions of L2 and L4 patterns (Table 1), and seven orphans showing 
similar patterns. It has been suggested that mixed infections in clinical specimens can challenge TB spoligotyping 
and sequencing techniques, and might have been the cause of false spoligotypes previously reported37,38. MANU2 
spoligotype has been suggested to be one of the five genotypes derived from mixed infections in clinical speci-
mens39. Studies showing the prevalence of MANU2 and discussing a link between MANU2 and mixed infection 
have been conducted in Iran37, Mozambique40, and Sudan41. The study in Mozambique concluded that some of 
the MANU2 genotypes could be derived from mixed infections of L2/Beijing and L4/T1, or L2/Beijing and L4/
T2. Further studies on samples showing “mixed” patterns are required to more fully establish whether polyclonal 
infections (from either coinfection or superinfection) are present in the Balimo/Bamu region of PNG. This infor-
mation may be epidemiologically relevant as it may indicate high contact rates of individuals with diverse Mtb 
strains.
Typical L2/Beijing strains are reported at high frequency worldwide and have been associated with drug 
resistance and increased transmissibility42,43. Sequencing of a 147-bp rpoB region identified seven samples as 
RIF-resistant, all presenting the rpoB S450L codon mutation. This is in agreement with previous findings in 
the Balimo/Bamu region WP44 and in South Fly District WP12 and other provinces in PNG8,9. All RIF-resistant 
samples belonged to the L2/Beijing Lineage, as found in Vietnam30,45. Molecular epidemiological studies have 
suggested that certain Mtb genotypes are more successful than others, including some L2/Beijing genotypes that 
have a higher fitness and have evolved unique pathogenic characteristics42,46,47. Phylogenetic analysis has pro-
vided evidence that the more recently diversified strains (so-called modern/typical Beijing L2.3) are adapted to 
spread and cause disease, compared to other sublineages (so-called ancient/atypical Beijing L2.2 or proto-Beijing, 
L2.1)48. On Daru Island in the South Fly District WP, a drug-resistant TB outbreak was recently characterized 
using WGS and was found to be driven by a Beijing L2.2.1.1 strain12, corresponding to a modern Beijing L2.3 in 
the latest classification from Liu and colleagues48. Unfortunately, our study did not provide any information at 
the sublineage level regarding the L2/Beijing strains. To complement our spoligotyping, further genomic studies 
of this sublineage in the Balimo/Bamu region of PNG will be needed to assess the presence of super-spreaders, 
association with drug resistance, or any other genetic signature of epidemiological interest.
Our study confirms the limitation that clean spoligotyping results can be obtained mostly from AFB 3+ and 
2+ slides. Nevertheless, the collected information about genetic diversity is invaluable for better understanding 
the epidemiology of TB, and archived smear slides are of sufficient quality to collect such data, as seen in this 
study. It is likely that prior targeted enrichment techniques may have improved our direct genotyping results from 
sputum smears49,50. However, such methods are not yet appropriate to local processing of samples. Before more 
sensitive methods can be introduced in countries such as PNG, huge numbers of archived smear slides could be 
used for retrospective and prospective studies of Mtb diversity.
In summary we demonstrate that, in countries where conservation of samples might be an issue, and/or hos-
pital laboratories do not have the capacity for culture or Xpert MTB/RIF-based diagnosis of TB, uncultured 
biological material could be used to obtain rich genomic information using archived sputum smears. Increasing 
local in vitro diagnostic capacities using devices such as the GeneXpert (Cepheid, USA) is important to increase 
awareness and improve public health. Alternatively, research on efficiency of new lab-on-chip devices, that should 
be as simple and inexpensive as possible to be used in level 1 laboratories and run as close as possible to the bed-
side of the patient, could be another way to improve TB control in rural regions of PNG.
Methods
Study setting and sample collection. BDH is located in the town of Balimo in the Middle Fly District 
WP, PNG. Passive case detection for TB is conducted at BDH among individuals self-presenting for health care. 
Presumptive TB cases presenting at BDH were from the Balimo Urban, Gogodala Rural, and Bamu Rural LLG 
areas, i.e. three of the five LLGs belonging to the Middle Fly District WP. Sputum samples are collected routinely 
for diagnostic purposes from patients with clinical signs of TB, and are ZN-stained and examined for AFB (acid-
fast bacilli) by light microscopy, with slides then archived and stored. Each sputum sample was smeared on sev-
eral slides, with up to five slides per sputum sample (see14 for details). Archived slides were transferred to James 
Cook University, in Townsville, Australia, for DNA extraction from the sputum smears.
rpoB result n % of 162 % of 115
WT 100 61.7% 87.0%
Probable WTa 6 3.7% 5.2%
S450Lb (C1349T) 9 5.6% 7.8%
N/A 46 28.4% —
Not matched to ref 1 0.6% —
Total 162 100% 100%
Table 2. Summary of sequencing results for the rpoB amplicons, including nucleotide and codon mutations. n: 
number of samples; WT: wild-type (no mutations identified); N/A: not available (PCR amplification or sequencing 
failed); Not matched to ref: obtained sequence not matching the MTB H37Rv reference genome; aFew nucleotides 
missing at positions other than those associated with resistance, otherwise matching wild type; bCodon mutation 
located within the RRDR of the rpoB gene, numbered according to the system based on MTB H37Rv.
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DNA extraction and detection of Mycobacterium species. DNA extracts were obtained using a mod-
ified version of a previously described Chelex DNA extraction method in biosafety level 2 laboratories21; the 
modified protocol has been published elswhere14. The presence of MTBC in the extracted DNA was analyzed 
using a TaqMan real-time PCR51 and the molecular diagnosis results have been published elsewhere14. Regarding 
duplicate sputum smears (i.e. originating from a single patient), only the smear showing the lowest Cq value was 
selected for further analysis. DNA aliquots were sent to the Institute for Integrative Cell Biology (Gif-sur-Yvette, 
France) for high-throughput spoligotyping.
Microbead-based spoligotyping. Microbead-based hybridization was performed as previously described10,23 
using the ‘TB-SPOL’ kits purchased from Beamedex (Beamedex, Orsay, France; www.beamedex.com). Detection 
was performed using a Luminex® 200 platform (Luminex Corp, Austin, TX, USA) and XPONENT software for 
LX100/LX200 (version 3.1.871.0). Interpretation of raw data was undertaken jointly by two experts (CS, GR) who 
idependently assessed spoligotyping patterns as previously described52. When no clear-cut interpretation was pos-
sible, typing was considered as failed; in other cases, intermediate quantitative signals for some spacers only allowed 
categorization of the samples as “mixed patterns” (see Discussion). Individual spoligotyping patterns were further 
compared with the International Spoligotyping Database (SITVIT2) of Pasteur Institute of Guadeloupe (http://www.
pasteur-guadeloupe.fr:8081/SITVIT2/indexfr.jsp), the latest updated release of SITVITWEB database32. Shared 
International Types (SIT) and spoligotype lineages and families were assigned according to signatures provided in 
SITVIT2 and to the latest genome-based lineage designations, i.e. L1-L7 Lineage labels and sublineage labels when 
possible, according to53 and34. Spoligotyping patterns absent in SITVIT2 were reported as “orphans”, as well as the 
patterns already described as “orphans” in the SITVIT2 database with no assigned SIT. Additional exploration of the 
family to which strains belonged was performed using TBminer (https://info-demo.lirmm.fr/tbminer/)54. This tool 
provides assignation according to different classifications that largely overlap. Contradictory assignations between 
the different classifications are indicative of either newly described subfamilies or of artefacts in the genotyping data 
(unpublished results). Spoligotyping from smear slides has previously shown better results with AFB-positive sputa 
quantified as '2+' and '3+' because of higher DNA loads55. However, instead of using microscopy results, we took 
into account Cq values obtained from qPCR targeting MTBC to select samples showing high DNA loads (see14 for 
detailed qPCR results). The Cq cutoff to be used was chosen from preliminary spoligotyping results.
rpoB mutations analysis. MDR/RR-TB was inferred from drug resistance-associated gene mutations of 
Mtb, focusing on the well-described rpoB gene. A qPCR was used to identify mutations in the rpoB gene using the 
DNA extracted from the TB clinical samples as a template. The rpoB primer set generating a 147-bp product was 
designed in-house and synthesized by Macrogen Inc. (Republic of Korea): Mtb-rpoB-147-F (5′-ATC AAG GAG 
TTC TTC GGC ACC AG-3′) and Mtb-rpoB-147-R (5′-CAC GTC GCG GAC CTC CAG-3′). Each qPCR reaction 
(20 μL) contained 1X GoTaq qPCR Master Mix (Promega, Madison, USA), 0.8 μM each of forward and reverse 
primer, and 2 μL of DNA template. The positive control used MTB H37Rv (GenBank: AL123456.3). Thermal 
cycling was as follows: hold at 95 °C for 2 min, followed by 45 cycles of 95 °C for 5 s and 60 °C for 15 s. Melting 
curve analysis was performed at a linear temperature transition rate of 0.1 °C/s from 70 to 95 °C. The qPCR 
assays were optimized and undertaken on a Rotor-Gene qPCR machine (Rotor-Gene software version 2.0.2.4). 
Samples that were reactive (Cq ≤ 38) were sequenced in both directions (Macrogen Inc., Republic of Korea). 
Sequence chromatograms were analysed using Geneious R10 (Biomatters Limited, Auckland, New Zealand), 
with the consensus sequences of each sample aligned with and compared to the MTB H37Rv reference sequence 
(GenBank: AL123456.3) using the “Map to Reference” Geneious tool. The consensus numbering system used for 
the RIF-resistance associated rpoB gene mutations is according to that described previously for MTB H37Rv56.
Mapping the data. Patient data was obtained from the BDH TB patient and laboratory registers, with 
patient locations identified as the first residential address recorded. Each patient’s location was matched to a cen-
sus unit, based primarily on PNG census data obtained from the PNG National Statistical Office, or alternatively 
from the 2012 and 2017 PNG government election polling schedules57,58. Latitude and longitude coordinates were 
obtained from the PNG National Statistical Office and census data, based on census unit-level data for villages, 
and averaged coordinates of multiple census units for Balimo and larger villages where the precise census unit was 
unknown. Instances of alternate local names were checked and confirmed locally. Out of the 162 included sam-
ples, the residential address was not able to be determined for 14 (address absent from the register for 12 patients; 
unknown villages ‘Sarau’ and ‘Owa’ for two patients). Maps were created using a Mac OSX Version of QGIS v2.18 
Las Palmas de Gran Canaria59 (available from: http://www.kyngchaos.com/software/qgis). A licence-free PNG 
map with administrative areas (level 1) was downloaded as a shapefile from http://www.diva-gis.org/gdata.
ethics statement. Ethics approval was obtained from the PNG Medical Research Advisory Council and 
registered under the reference MRAC No. 17.02. The information sheet and written informed consent forms were 
available where required. However, the need for written informed consent was waived by the Ethics Committee 
due to generally low levels of literacy, and verbal consent was obtained in the majority of the cases. The study was 
conducted with the permission and support of the Middle Fly District Health Service and the Evangelical Church 
of PNG Health Service, and at all times permission was obtained prior to sampling activities.
Data availability
All data generated or analysed during this study are included in the published article.
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